A rectovaginal fistula after treatment with bevacizumab. A dangerous side effect needing emergency treatment.
Despite its effectiveness in the treatment of malignant tumors, bevacizumab is associated with a variety of side effects such as the formation of fistulas (i.e., tracheoesophageal, colovaginal, or rectovaginal). It is important to recognize immediately the emergence of this entity in order to discontinue bevacizumab permanently and treat the fistula.
Department of Gastroenterology"401" General Military Hospital of Athens Athens Greece; Department of Gastroenterology General Hospital of Athens "Evaggelismos"Athens Greece.
Michail
0000-0002-7544-2810
M
Galanopoulos
1st Internal Medicine Department 401 Army General Hospital of Athens Athens Greece.
Spyridon
S
Ladias
Department of Gastroenterology General Hospital of Athens "Evaggelismos" Athens Greece.
Xanthippi
X
Tzannetakou
Department of Gastroenterology General Hospital of Athens "Evaggelismos" Athens Greece.
Athanasios
A
Tsigaridas
Department of Plastic Surgery Papageorgiou General Hospital of Thessaloniki Thessaloniki Greece.
Alexandros
A
Sarafis
Department of Gastroenterology "401" General Military Hospital of Athens Athens Greece.
Christos
C
Liatsos
Department of Gastroenterology "401" General Military Hospital of Athens Athens Greece.
Evangelos
E
Kalafatis
Bevacizumab; Over‐The‐Scope Clip; rectovaginal fistula